SCIENCE

Mellanox Technologies intends to conduct, subject to market and other conditions, an underwritten public offering of 3,000,000 ordinary shares pursuant to an effective shelf registration statement. Mellanox Technologies also expects to grant the underwriters of the offering a 30-day option to purchase up to an additional 450,000 ordinary shares in the public offering to cover over-allotments, if any. J.P. Morgan Securities LLC, Credit Suisse Securities (USA) LLC and Barclays Capital Inc. are acting as the book running managers for the offering. Stifel Nicolaus Weisel is acting as co-manager for the offering.

Mellanox Technologies intends to use the net proceeds from the offering for general corporate purposes, including working capital and potential strategic investments.

The public offering of the ordinary shares is being made by means of a prospectus and prospectus supplement pursuant to an automatic universal shelf registration statement that was filed earlier today with the Securities and Exchange Commission and became effective immediately upon filing. Copies of the prospectus supplement and base prospectus relating to this offering may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, Attn: Prospectus Department, 1155 Long Island Avenue, Edgewood, New York 11717, (866) 803-9204, Credit Suisse Securities (USA) LLC, Prospectus Department, One Madison Avenue, New York, NY 10010, (800) 221-1037, and Barclays Capital Inc., c/o Broadridge Financial Solutions, 1155 Long Island Ave., Edgewood, NY 11717, (888) 603-5847.